MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from royalty
purchase and sale...
$2,895K
Proceeds from shares
issued under employee...
$10K
Net cash provided by
financing activities
$2,905K
Net decrease in cash
and cash...
-$2,575K
Canceled cashflow
$2,905K
Non-cash interest
expense on liability...
$2,570K
Prepaid expenses and
other current assets
-$956K
Share-based compensation
expense
$746K
Depreciation
$84K
Net cash used in
operating activities
-$5,480K
Canceled cashflow
$4,356K
Net loss
-$5,972K
Change in fair value of
warrant liabilities
-$3,573K
Accounts payable and
accrued liabilities...
-$280K
Other assets and
liabilities
$11K
Back
Back
Cash Flow
source: myfinsight.com
Clearside Biomedical, Inc. (CLSD)
Clearside Biomedical, Inc. (CLSD)